Tuesday, Sep 23, 2025 · SEC filings
What the smart money revealed on Sep 23
268 insider filings came in. We hid 43 planned (10b5-1) sellers and 160 people whose filings were routine, like grants and tax withholding.
3 insiders at BioCardia (BCDA) bought $918K of stock
Roles: CEO, Director. Several insiders buying in the same few days is rare.
3 insiders at Culp (CULP) bought $66.3K of stock
Roles: CEO, Chief Commercial Officer, Director. Several insiders buying in the same few days is rare.
Biodesix (BDSX) Director Jack Schuler bought $1M
142,045 shares on the open market. Not a grant or an option exercise.
GrowGeneration (GRWG) Director Stephen Aiello bought $221K
133,334 shares on the open market. Not a grant or an option exercise.
Archrock (AROC) Director Jason Rebrook bought $120K
5,000 shares on the open market. Not a grant or an option exercise.
Butler National (BUKS) Director Joseph Daly bought $85.1K
47,425 shares on the open market. Not a grant or an option exercise.
NVIDIA (NVDA) Director Mark Stevens sold $61.7M
Not marked as a planned 10b5-1 sale. Sold 5% of the shares they held directly. Still holds 7.4M shares.
Gitlab (GTLB) Director Matthew Jacobson sold $11.7M
Not marked as a planned 10b5-1 sale. Sold 94% of the shares they held directly. Still holds 14,207 shares.
Alzamend Neuro (ALZN) Director Milton Ault sold $181K
Not marked as a planned 10b5-1 sale. Sold 90% of the shares they held directly. Still holds 8,260 shares.
Show 9 more real buys
Show 21 more real sales
13F season
Holdings as of Jun 30, 2025 were due Aug 14
74 funds have filed. 68 filed for the quarter before.
Biggest real insider buys, Sep 17–23
Open-market buys by officers and directors, filed in the 7 days up to Sep 23.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.